Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles von Arvizo, Rochelle R, Miranda, Oscar R, Moyano, Daniel F, Walden, Chad A, Giri, Karuna, Bhattacharya, Resham, Robertson, J David, Rotello, Vincent M, Reid, Joel M, Mukherjee, Priyabrata

Volltext

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism von Camacho-Pereira, Juliana, Tarragó, Mariana G., Chini, Claudia C.S., Nin, Veronica, Escande, Carlos, Warner, Gina M., Puranik, Amrutesh S., Schoon, Renee A., Reid, Joel M., Galina, Antonio, Chini, Eduardo N.

Volltext

Synchrotron powder diffraction data for some smectite clay mineral standards von Reid, Joel W.

Volltext

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial von Davis, Kara L, Fox, Elizabeth, Merchant, Melinda S, Reid, Joel M, Kudgus, Rachel A, Liu, Xiaowei, Minard, Charles G, Voss, Stephan, Berg, Stacey L, Weigel, Brenda J, Mackall, Crystal L

Volltext

Pharmacokinetics of Intravitreal Bevacizumab (Avastin) von Bakri, Sophie J., MD, Snyder, Melissa R., PhD, Reid, Joel M., PhD, Pulido, Jose S., MD, Singh, Ravinder J., PhD

Volltext

Controlled Delivery of Vancomycin via Charged Hydrogels von Gustafson, Carl T, Boakye-Agyeman, Felix, Brinkman, Cassandra L, Reid, Joel M, Patel, Robin, Bajzer, Zeljko, Dadsetan, Mahrokh, Yaszemski, Michael J

Volltext

Pharmacokinetics of Intravitreal Ranibizumab (Lucentis) von Bakri, Sophie J., MD, Snyder, Melissa R., PhD, Reid, Joel M., PhD, Pulido, Jose S., MD, Ezzat, Mohamed K., BS, Singh, Ravinder J., PhD

Volltext

Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside von Jayaraman, Swaathi, Reid, Joel M, Hawse, John R, Goetz, Matthew P

Volltext

Silicon substitution in the calcium phosphate bioceramics von Pietak, Alexis M, Reid, Joel W, Stott, Malcom J, Sayer, Michael

Volltext

Powder X-ray diffraction data for dimethylarsinic acid, (CH3)2AsO(OH) von Reid, Joel W.

Volltext

Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Childre... von Kopp, Lisa M., Malempati, Suman, Krailo, Mark, Gao, Yun, Buxton, Allen, Weigel, Brenda J., Hawthorne, Thomas, Crowley, Elizabeth, Moscow, Jeffrey A., Reid, Joel M., Villalobos, Victor, Randall, R. Lor, Gorlick, Richard, Janeway, Katherine A.

Volltext

Entinostat as a combinatorial therapeutic for rhabdomyosarcoma von Chauhan, Shefali, Lian, Emily, Habib, Iman, Liu, Qianqian, Anders, Nicole M., Bugg, Megan M., Federman, Noah C., Reid, Joel M., Stewart, Clinton F., Cates, Tristan, Michalek, Joel E., Keller, Charles

Volltext

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits von Chowdhury, Uttio Roy, Kudgus, Rachel A., Rinkoski, Tommy A., Holman, Bradley H., Bahler, Cindy K., Hann, Cheryl R., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.

Volltext

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortiu... von BENDER, Julia L. Glade, LEE, Alice, WEIGEL, Brenda J, BLANEY, Susan M, REID, Joel M, BARUCHEL, Sylvain, ROBERTS, Timothy, VOSS, Stephan D, BING WU, AHERN, Charlotte H, INGLE, Ashish M, HARRIS, Pamela

Volltext

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921) von Mossé, Yael P, Fox, Elizabeth, Teachey, David T, Reid, Joel M, Safgren, Stephanie L, Carol, Hernan, Lock, Richard B, Houghton, Peter J, Smith, Malcolm A, Hall, David, Barkauskas, Donald A, Krailo, Mark, Voss, Stephan D, Berg, Stacey L, Blaney, Susan M, Weigel, Brenda J

Volltext

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma von Kim, Jin-Ah, Crawford, Kenneth A., Spada, Piero A., Martin, Leah R., Zhang, Jiaqi, Wong, Rain, Reid, Joel M., Stewart, Clinton F., Frank, Timothy M., Liu, Qianqian, Michalek, Joel E., Keller, Charles

Volltext

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approac... von DuBois, Steven G, Marachelian, Araz, Fox, Elizabeth, Kudgus, Rachel A, Reid, Joel M, Groshen, Susan, Malvar, Jemily, Bagatell, Rochelle, Wagner, Lars, Maris, John M, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Matthay, Katherine K, Mosse, Yael P

Volltext

Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review von Barreto, Erin F., Rule, Andrew D., Murad, M. Hassan, Kashani, Kianoush B., Lieske, John C., Erwin, Patricia J., Steckelberg, James M., Gajic, Ognjen, Reid, Joel M., Kane-Gill, Sandra L.

Volltext

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group von MALEMPATI, Suman, WEIGEL, Brenda, CHEN, Helen X, KRAILO, Mark D, ADAMSON, Peter C, BLANEY, Susan M, INGLE, Ashish M, AHERN, Charlotte H, CARROLL, Julie M, ROBERTS, Charles T, REID, Joel M, SCHMECHEL, Stephen, VOSS, Stephan D, CHO, Steven Y

Volltext

A Phase 1 Study of ABI‐009 (Nab‐sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors—A C... von Cramer, Stuart L., Reddy, Alyssa Terry, Minard, Charles Gene, Voss, Stephan, Fox, Elizabeth, Liu, Xiaowei, Denic, Kristina, Reid, Joel M., Weigel, Brenda J.

Volltext